Q1 2016

Filed May 16, 2016 · 10-Q · 46 days after period end · 0001437749-16-032004

Q1 2016 · 10-Q

Revenue

$13.94K

−47.7% vs Q1 2015

Net Income

-$1.64M

N/M vs Q1 2015

EPS Diluted

-$0.02

N/M vs Q1 2015

Gross Profit$7,861+4.9%

Operating Income

Same quarter

Metric	Q1 2016	Q1 2015	Q1 2014	Q1 2013
Revenue	$13.94K	$26.67K	$9.29K	$14.36K
Net Income	-$1.64M	-$780.43K	-$1.02M	-$645.30K
EPS Diluted	-$0.02	-$0.01	-$0.01	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR